提高至30% 山东扩大基层医疗机构非基本药物使用比例

2017-07-21 李振 新锐大众

此次调整意味着基层医疗机构可用的非基药将有所增加,也是为了促进基层医疗机构与二三级医疗机构的用药衔接。

基层能用到更多的非基本药物了!7月20日,山东省卫计委在官网上公布了《关于调整完善基层医疗卫生机构药品配备使用政策的通知》(以下简称《通知》),将基层医疗机构非基本药物采购金额占本机构药品采购总金额比例提高至30%,这对于满足患者基层就诊的用药需求,促进双向转诊和分级诊疗制度的用药衔接有积极意义。

基药制度建立以来,用药难一直困扰着基层医疗机构:基药缺药、常用药不在基药目录、廉价基药不受认可等问题的存在使得基层医生常有“无药可用”的感觉,同时也为患者选择基层就诊增添麻烦:因为买不到需要的要,有的患者在基层医疗机构看了病不得不去大医院拿药。尤其是近年来随着基层医疗能力水平的逐步提高,医联体和分级诊疗制度的逐步建立,越来越多的慢病患者、医联体内就诊患者以及恢复期转诊患者需要在基层医疗机构看病、拿药。

为满足患者用药需求,促进基层医疗机构与二三级医疗机构间的用药衔接,此次《通知》对此前对基层医疗机构的药品配备使用情况进行了调整。

此前,山东省曾要求基层医疗卫生机构基本药物采购金额占全部药品采购总金额的比例不低于80%,也就是说非基药的采购总金额比例不高于20%。此次,《通知》将基层医疗机构非基药采购金额占本机构药品采购总金额的比例调整至不得超过30%。这意味着基层医疗机构可用的非基药将有所增加,基层医生可使用的非基药范围有所扩大。

对于基层可用哪些非基药,《通知》规定,以保障慢性病患者用药为重点,基层医疗卫生机构可直接从山东基本医疗保险药品目录中自主选择非基药。非基药遴选权的下沉意味着基层医疗机构可根据临床一线的实际需求选择、调整用药范围,大大提高基层用药选择的灵活性。

针对可能隐藏灰色交易、引发药价虚高的网下采购,此次《通知》要求,基层医疗机构配备使用的所有药品(中药饮片除外)必须通过山东药品集中采购平台进行网上采购,并实行以省为单位货款统一结算,零差率销售。

链接:

基本药物指的是能够满足基本医疗卫生需求,剂型适宜、保证供应、基层能够配备、国民能够公平获得的药品,主要特征是安全、必需、有效、价廉。如青霉素、红霉素、藿香正气水等。

2009年8月,《关于建立国家基本药物制度的实施意见》《国家基本药物目录管理办法(暂行)》和《国家基本药物目录(基层医疗卫生机构配备使用部分)》(2009版)同时发布,自此我国建立国家基本药物制度工作正式实施。政府举办的基层医疗卫生机构全部配备和使用基本药物,其他各类医疗机构也都必须按规定使用基本药物。

凡是纳入医保报销基本目录范围的药物,因病情需要使用且符合医保相关报销规定的,均能得到一定比例的报销。基本药物如此,非基本药物也是如此。基本药物与非基本药物在医保报销方面的不同有:一是基本药物全部纳入基本医疗保障药品报销目录的范围,而非基本药物仅有部分纳入;二是国家鼓励使用基本药物,基本药物的报销比例明显高于非基本药物。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1971541, encodeId=d62919e15419d, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Tue Aug 01 00:32:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665459, encodeId=fed616654594c, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Fri Sep 22 23:32:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298368, encodeId=c82a129836816, content=<a href='/topic/show?id=ac55350442f' target=_blank style='color:#2F92EE;'>#医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35044, encryptionId=ac55350442f, topicName=医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 23 02:32:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487335, encodeId=725c148e3350a, content=<a href='/topic/show?id=0d0141984ec' target=_blank style='color:#2F92EE;'>#基层医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41984, encryptionId=0d0141984ec, topicName=基层医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe8a8300523, createdName=mei534, createdTime=Sun Jul 23 02:32:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224627, encodeId=2e6622462eee, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jul 21 12:24:21 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1971541, encodeId=d62919e15419d, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Tue Aug 01 00:32:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665459, encodeId=fed616654594c, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Fri Sep 22 23:32:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298368, encodeId=c82a129836816, content=<a href='/topic/show?id=ac55350442f' target=_blank style='color:#2F92EE;'>#医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35044, encryptionId=ac55350442f, topicName=医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 23 02:32:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487335, encodeId=725c148e3350a, content=<a href='/topic/show?id=0d0141984ec' target=_blank style='color:#2F92EE;'>#基层医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41984, encryptionId=0d0141984ec, topicName=基层医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe8a8300523, createdName=mei534, createdTime=Sun Jul 23 02:32:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224627, encodeId=2e6622462eee, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jul 21 12:24:21 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1971541, encodeId=d62919e15419d, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Tue Aug 01 00:32:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665459, encodeId=fed616654594c, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Fri Sep 22 23:32:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298368, encodeId=c82a129836816, content=<a href='/topic/show?id=ac55350442f' target=_blank style='color:#2F92EE;'>#医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35044, encryptionId=ac55350442f, topicName=医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 23 02:32:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487335, encodeId=725c148e3350a, content=<a href='/topic/show?id=0d0141984ec' target=_blank style='color:#2F92EE;'>#基层医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41984, encryptionId=0d0141984ec, topicName=基层医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe8a8300523, createdName=mei534, createdTime=Sun Jul 23 02:32:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224627, encodeId=2e6622462eee, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jul 21 12:24:21 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1971541, encodeId=d62919e15419d, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Tue Aug 01 00:32:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665459, encodeId=fed616654594c, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Fri Sep 22 23:32:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298368, encodeId=c82a129836816, content=<a href='/topic/show?id=ac55350442f' target=_blank style='color:#2F92EE;'>#医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35044, encryptionId=ac55350442f, topicName=医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 23 02:32:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487335, encodeId=725c148e3350a, content=<a href='/topic/show?id=0d0141984ec' target=_blank style='color:#2F92EE;'>#基层医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41984, encryptionId=0d0141984ec, topicName=基层医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe8a8300523, createdName=mei534, createdTime=Sun Jul 23 02:32:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224627, encodeId=2e6622462eee, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jul 21 12:24:21 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1971541, encodeId=d62919e15419d, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Tue Aug 01 00:32:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665459, encodeId=fed616654594c, content=<a href='/topic/show?id=369f421062f' target=_blank style='color:#2F92EE;'>#基本药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42106, encryptionId=369f421062f, topicName=基本药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=861725964512, createdName=ms9203727104890838, createdTime=Fri Sep 22 23:32:00 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1298368, encodeId=c82a129836816, content=<a href='/topic/show?id=ac55350442f' target=_blank style='color:#2F92EE;'>#医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35044, encryptionId=ac55350442f, topicName=医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Jul 23 02:32:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487335, encodeId=725c148e3350a, content=<a href='/topic/show?id=0d0141984ec' target=_blank style='color:#2F92EE;'>#基层医疗机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41984, encryptionId=0d0141984ec, topicName=基层医疗机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe8a8300523, createdName=mei534, createdTime=Sun Jul 23 02:32:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224627, encodeId=2e6622462eee, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Jul 21 12:24:21 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2017-07-21 137****9095

    henhao

    0

相关资讯

山东启动“公立医院改革跟踪审计”重点审查4个方面

“本次跟踪审计严格来说调查的意味更重一些。”负责此次审计的省审计厅相关工作人员表示。

部门办医将终结 山东省地矿职工医院整建制并入千佛山医院

据山东省千佛山医院副院长任勇介绍,此次合并是山东省地矿职工医院整体融入省千佛山医院,包括其所属2个社区卫生服务机构、共53人,以及原有建筑、土地等。

山东17市469家公立医院改革 县域就诊率近90%

山东469家公立医院综合改革全面推开,全部取消药品加成,实行零差率销售。青岛、烟台、威海被确定为国家级医养结合试点市。

山东:所有三级公立医院年内启动医联体建设

今年,每个市至少建成2个有明显成效的医联体,三级公立医院全部参与并发挥引领作用;明年,山东省所有县级医院将全部参与医联体建设,并加快向基层医疗卫生机构延伸。这是山东省人民政府办公厅近日印发的《山东省医疗联合体建设推进工作方案》提出的医联体建设工作目标。

CDE与山东省药监局达成战略合作 共同提升药品审评能力

为加快推进药品审评审批制度改革,促进国家总局及省局技术审评优势互补,共同推进药品技术审评能力建设,5月26日,国家食品药品监督管理总局药审中心与山东省食品药品监督管理局签署战略合作协议。总局副局长孙咸泽出席签字仪式并讲话。